Boiron SA - Asset Resilience Ratio

Latest as of December 2023: -0.13%

Boiron SA (BOI) has an Asset Resilience Ratio of -0.13% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BOI total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€-747.00K

≈ $-873.32K USD Cash + Short-term Investments

Total Assets

€590.20 Million

≈ $690.01 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2023)

This chart shows how Boiron SA's Asset Resilience Ratio has changed over time. See what is Boiron SA's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Boiron SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BOI market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€-747.00K	-0.13%
Total Liquid Assets	€-747.00K	-0.13%

Asset Resilience Insights

Limited Liquidity: Boiron SA maintains only -0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Boiron SA Industry Peers by Asset Resilience Ratio

Compare Boiron SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for Boiron SA (2001–2023)

The table below shows the annual Asset Resilience Ratio data for Boiron SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.13%	€-747.00K ≈ $-873.32K	€590.20 Million ≈ $690.01 Million	-0.09pp
2022-12-31	-0.03%	€-260.00K ≈ $-303.97K	€789.49 Million ≈ $923.00 Million	+0.02pp
2021-12-31	-0.05%	€-398.00K ≈ $-465.30K	€770.70 Million ≈ $901.03 Million	0.00pp
2020-12-31	-0.05%	€-397.00K ≈ $-464.13K	€781.82 Million ≈ $914.03 Million	+0.00pp
2019-12-31	-0.05%	€-411.00K ≈ $-480.50K	€764.28 Million ≈ $893.53 Million	-0.06pp
2015-12-31	0.01%	€41.00K ≈ $47.93K	€695.45 Million ≈ $813.05 Million	+0.49pp
2012-12-31	-0.48%	€-2.79 Million ≈ $-3.26 Million	€579.28 Million ≈ $677.24 Million	-0.92pp
2001-12-31	0.44%	€905.00K ≈ $1.06 Million	€205.86 Million ≈ $240.67 Million	--

pp = percentage points

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic

Market Cap

$556.17 Million

€475.73 Million EUR

Market Cap Rank

#13010 Global

#194 in France

Share Price

€27.40

Change (1 day)

+4.58%

52-Week Range

€20.90 - €31.70

All Time High

€59.48